Michela Bardini

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 4

Top Topics

Gene Expression

Acute Lymphoblastic Leukemia

Acute Respiratory Distress Syndrome

Top Venues

Molecular cancer therapeutics

British journal of haematology

This page only lists publications with an associated author ORCID identifier.

Publications

Michela Bardini, Grazia Fazio, Lilia Corral Abascal, Claus Meyer, Oscar Maglia, Simona Sala, Sonia Palamini, Stefano Rebellato, Rolf Marschalek, Carmelo Rizzari, Andrea Biondi, Giovanni Cazzaniga
Prenatal origin of NUTM1 gene rearrangement in infant B-cell precursor acute lymphoblastic leukaemia. British journal of haematology (2024)
Marius Külp, Patrizia Larghero, Julia Alten, Gunnar Cario, Cornelia Eckert, Aurélie Caye-Eude, Hélène Cave, Tessa Schmachtel, Michela Bardini, Giovanni Cazzaniga, Paola De Lorenzo, Maria Grazia Valsecchi, Halvard Bonig, Claus Meyer, Michael A Rieger, Rolf Marschalek
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome. Leukemia (2023)
Marius Külp, Patrizia Larghero, Julia Alten, Gunnar Cario, Cornelia Eckert, Aurélie Caye-Eude, Hélène Cave, Tessa Schmachtel, Michela Bardini, Giovanni Cazzaniga, Paola De Lorenzo, Maria Grazia Valsecchi, Halvard Bonig, Claus Meyer, Michael A Rieger, Rolf Marschalek
The EGR3 regulome of infant KMT2A-r acute lymphoblastic leukemia identifies differential expression of B-lineage genes predictive for outcome. Leukemia (2023)
Michela Bardini, Luca Trentin, Francesca Rizzo, Margherita Vieri, Angela M Savino, Patricia Garrido Castro, Grazia Fazio, Eddy H J Van Roon, Mark Kerstjens, Nicholas Smithers, Rab K Prinjha, Geertruy Te Kronnie, Giuseppe Basso, Ronald W Stam, Rob Pieters, Andrea Biondi, Giovanni Cazzaniga
Antileukemic Efficacy of BET Inhibitor in a Preclinical Mouse Model of MLL-AF4+ Infant ALL. Molecular cancer therapeutics 17 (8) (2018)